coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Westhoughton Network PCN, Bolton (LAD) · Health Inequalities Profile

    PCN U46071 · NHS Greater Manchester Integrated Care Board · 2 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    27,331

    Registered population

    58.2% aged 18–64

    22.9%

    Aged 65+

    ICB 14.9% · England 17.9%

    7.4%

    Ethnic minority (non-White)

    3.9% Asian · England 9.6%

    4.8%

    In IMD quintile 1

    ICB 40.7% · England 21.0%

    ~1,389

    Core20 residents (est.)

    Resident basis; registered basis ~1,326 · see page 3

    4,822

    Hypertension register

    +7.20% in 3 yrs · England +5.60%

    237

    SMI register

    6.5% of Bolton (LAD)'s

    634

    COPD register

    Reviews +24.48% in 3 yrs

    Forecast to 2030

    5,526

    Hypertension patients, 2030

    +704 on today

    60.1%

    QRISK ≥20% on statins, 2030

    +3.16pp over 3 yrs

    4.8%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    53.2%
    Lipid therapy trails England across high-risk registers.

    Lipid-lowering therapy for QRISK ≥ 20% is 53.2% (England 63.6%), alongside gaps in CKD (60.0% vs 70.3%) and diabetes without CVD (64.1% vs 73.2%).

    75.9%
    SMI physical health checks lag national averages.

    Annual SMI blood pressure recording is 75.9% (England 83.4%), while BMI recording (73.2% vs 82.1%) and psychosis alcohol recording (60.5% vs 81.8%) also trail.

    +38.3%
    Rapid three-year growth in annual asthma reviews.

    Asthma review coverage rose +38.3% over three years (England +4.4%) to 69.6% (England 65.7%), though a scale indicator of about 600 remain unreviewed.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Adults aged 65 and over make up 22.9% of registered patients, exceeding benchmarks

    Westhoughton Network PCN serves 27,331 registered patients across Unsworth Group Practice (20,186) and Stable Fold Surgery (7,145). Patients aged 65+ account for 22.9% of the list (6,258 patients; Stable Fold Surgery 24.0%, Unsworth Group Practice 22.5%), notably above Bolton (LAD) at 14.7%, the ICB at 14.9%, and England at 17.9%. In associated Census resident areas, 92.6% are White (Bolton 72.0%, ICB 76.4%, England 81.1%) and 3.9% Asian or Asian British. List growth is projected at 0.3% to 2030 (methodology unverified). Age uses registered patients; ethnicity reflects resident Census data.

    Age profile

    0–1718.9%
    18–6458.2%
    65+22.9%

    65+: ICB 14.9%, England 17.9%

    Ethnicity

    White92.6%
    Asian3.9%
    Mixed2.0%
    Black0.8%
    Other0.6%

    Older people · falls rows are Bolton (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Bolton LA)1,9232,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)78.2%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)54.5%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Bolton LA)9581,0219552024/25
    Falls deaths, all ages, per 100,000 (Bolton LA)19.018.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation is 4.8% PCN-wide, dividing outreach between practice concentration and volume

    At 4.8%, the Core20 share is below Bolton (LAD) at 47.8%, NHS Greater Manchester ICB at 40.7%, and England at 21.0%, reflecting an average IMD decile of 6.2 (Bolton 4.2, England 5.5). Stable Fold Surgery has the highest Core20 share at 6.8% (486 estimated patients), whereas Unsworth Group Practice has the highest volume at 840 estimated patients (4.2%). Modelled practice estimates rest on list shares rather than direct headcounts. Outreach should balance concentrated engagement where deprivation is densest against routine capacity where volume is largest.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Stable Fold6.8% · 486 patients
    Unsworth4.2% · 840 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    237

    SMI register

    0.86% recorded prevalence

    167

    Learning disability register

    0.61% recorded prevalence

    5

    Care homes, 211 beds

    In the PCN catchment

    9.8%

    Provide unpaid care

    Bolton (LAD), Census 2021

    The PCN records 167 learning disability patients (0.6%, matching Bolton, ICB, and England at 0.6%) and 237 on the severe mental illness register (0.9%, trailing Bolton at 1.1%, the ICB at 1.1%, and England at 1.0%). Catchment infrastructure includes 5 care homes with 211 beds. Lower recorded SMI prevalence does not establish undiagnosed disease or coding variation, which practice audits could assess.

    Severe mental illness: physical health checks

    Across 237 SMI patients, annual checks trail England for blood pressure at 75.9% (England 83.4%; Unsworth Group Practice 72.5%), BMI at 73.2% (England 82.1%), and alcohol at 60.5% (England 81.8%). Auditing checks helps address trailing physical health monitoring.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    4,822

    Hypertension register

    +7.20%

    Register growth, 3 yrs

    Bolton (LAD) +4.70% · England +5.60%

    +4.61pp

    BP control, under 80

    ≤140/90 · +3.95pp aged 80+

    +704

    More patients by 2030

    Forecast 5,526 (20.16%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 17.5% (4,822 patients), higher than England (15.2%), Bolton (14.8%), and the ICB (14.4%). Among patients aged under 80, 70.2% meet the blood pressure target (England 67.8%), while overall 70.9% are treated to target (England 70.3%). However, for patients aged 80 and over, blood pressure control trails England at 80.9% versus 81.2% (Unsworth Group Practice at 79.4%, Stable Fold Surgery at 85.0%). Crude prevalence does not adjust for the PCN's older demographic (22.9% aged 65+). Higher prevalence alongside trailing blood pressure control in older cohorts indicates an operational priority to review management for patients aged 80 and over, particularly at Unsworth Group Practice.

    Lipids and statins

    Lipid-lowering therapy trails England across key risk cohorts: QRISK ≥ 20% at 53.2% (England 63.6%), CKD at 60.0% (England 70.3%), and diabetes without CVD at 64.1% (England 73.2%). Fewer at-risk patients receive lipid-lowering therapy than benchmark rates imply, meaning systematic recall audits across these primary prevention cohorts should be prioritised.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202641,153£2.30£1.94£1.86£94,652
    Cardiovascular (all), 202568,720£4.71£3.15£3.33£323,671

    In 2026, the PCN prescribed 41,153 lipid-modifying items at £2.30 per item, above England (£1.86), Bolton (£1.81), and the ICB (£1.94). The PCN spent £18,107 more than at England's unit cost across these items. Higher unit costs alongside lower treatment coverage indicate an opportunity to review lipid-modifying prescribing choices while expanding therapy.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +38.26%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +1.41%

    Asthma prevalence, PCN 3-yr % change

    Over three years, recorded review rates improved +38.3% for asthma (England +4.4%) and +24.5% for COPD (England +2.8%). Asthma prevalence is 7.6% (1,971 patients; England 6.6%), with 69.6% reviewed in the last 12 months (England 65.7%), leaving about 600 patients unreviewed. COPD prevalence is 2.3% (634 patients; England 1.9%), with reviews at 76.0% (England 76.4%). Prescribing of asthma items for ages 5-19 reaches 1,965 per 1,000 (England 1,488). Review gains are substantial, but unreviewed asthma cohorts warrant proactive scheduling.

    Cancer register and children's immunisation

    Cancer prevalence is 4.4% (1,206 patients; England 3.8%). Childhood immunisations exceed benchmarks early, with age-2 MMR1 at 98.5% (England 88.3%). However, at age 5, MMR2 and 4-in-1 booster coverage both fall to 91.1%, sitting 3.9 pp below the 95.0% target. Unsworth Group Practice shows a 6.7 pp drop between first (95.6%) and second (88.9%) MMR doses. Pre-school booster recalls are needed to prevent drop-off before school entry.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months98.1%

    England 91.0%

    6-in-1 complete primary course at 24 months98.5%

    England 92.2%

    MMR dose 1 at 24 months98.5%

    England 88.3%

    MMR dose 2 at age 591.1%

    England 82.8%

    4-in-1 pre-school booster at age 591.1%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Greater Manchester ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,270

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Greater Manchester ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%15%2,193
    Prostate61.7%53.2%14%1,788
    Breast82.5%85.4%19%1,758
    Bowel46.3%47.0%19%1,427
    Skin cancer84.5%87.8%27%580

    In NHS Greater Manchester ICB (2022), 55.6% of staged cancers (6,491 of 11,679) were diagnosed at stage 1 or 2 (England 55.3%), sitting 19.4 pp below the 75.0% ambition by 2028 (known stage share 70.8%). Reaching this ambition requires about 2,270 extra early diagnoses annually across the ICB. Staging varied between breast (82.5%), lung (40.4%), and oesophagus (22.4%). System staging does not reflect PCN performance, though three-year PCN cancer register growth was +4.8% (England +9.0%). Slower register growth could reflect coding or referral patterns, which local audits could test.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In Jul 2026, Bolton NHS Foundation Trust achieved 80.5% on the 28-day faster diagnosis standard, exceeding the 75.0% standard, Manchester University NHS Foundation Trust (80.1%), the ICB (79.5%), and England (79.3%), while behind Wrightington, Wigan and Leigh Teaching Hospitals NHS Foundation Trust (82.8%). Bolton achieved 69.7% on the 62-day standard, trailing 15.3 pp below the 85.0% target (ICB 75.7%, England 71.2%). For diagnostics, 15.8% waited 6+ weeks at Bolton (England 23.1%), including computed tomography at 19.4% and colonoscopy at 1.3%. These trust metrics reflect secondary care pathways rather than PCN performance.

    Pathways within standard (%)BoltonWrightington, Wigan and LeighManchesterGreater Manchester ICBEngland
    28-day faster diagnosis (75%)80.4882.8080.0679.5379.32
    31-day treatment (96%)96.5089.0492.5496.4992.50
    62-day referral to treatment (85%)69.6676.7872.8575.7371.16
    Diagnostic waits over 6 weeks (%)BoltonWrightington, Wigan and LeighManchesterEngland
    MRI2.050.4911.6821.40
    CT19.407.7814.669.92
    Echocardiography3.4824.374.9128.48
    Colonoscopy1.336.104.5130.83
    Gastroscopy2.0612.5429.3529.02
    All 15 DM01 tests15.7814.368.9823.14
    Community services activityBolton residentsGreater Manchester ICB
    Care contacts49,315573,310
    Referrals4,07594,470
    Patients with a contact17,765183,535

    Community services (residents of Bolton), Jun 2026 (provisional). In Jun 2026, 17,765 Bolton residents had a recorded community care contact across 49,315 contacts and 49,135 activities (ICB: 183,535 patients; 573,310 contacts). Bolton recorded 4,075 community referrals for 3,330 patients. Adults aged 65+ accounted for 51.6% of borough contacts (25,460). High community contact volume among older residents underscores the importance of coordinated primary and community nursing links for managing post-diagnosis cancer and frailty care.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Phone access diverges by 23.3 pp across practices while clinical achievement remains high

    In 2025/26, overall QOF achievement was 94.8% at Unsworth Group Practice and 90.6% at Stable Fold Surgery (England 92.5%). Vaccination and immunisation domain achievement reached 74.7% at Unsworth Group Practice and 61.4% at Stable Fold Surgery (England 55.2%, a 13.3 pp range). High points delivery demonstrates recorded clinical activity, though points do not establish unique population reach.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Stable Fold1016.844.7%73.9%77.1%
    Unsworth774.221.4%75.9%70.5%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNBolton (LAD)AssetPCNBolton (LAD)
    Care homes (catchment)5 (211 beds)n/aSchools (catchment)20n/a
    Children's centres118Places of worship15144
    Libraries27Primary schools (LA maintained)961
    Primary academies132Special schoolsn/a3

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Lipid therapy recall and prescribing review

    Lipid-lowering therapy trails England for QRISK ≥ 20% at 53.2% (England 63.6%), CKD at 60.0% (England 70.3%), and diabetes without CVD at 64.1% (England 73.2%). Lipid-modifying items cost £2.30 (England £1.86), £18,107 more than England's unit cost across 41,153 items. Moderate effort to run.

    Evidence base: delivery measure for eight care processes and three treatment targets; shortfall here is what shows up later as emergency admission.

    Policy anchor: NHS Diabetes Prevention Programme and the eight care processes / three treatment targets.

    Option 2

    Combined SMI physical health check recall

    Across 237 SMI patients (0.9% prevalence vs 1.0% England), annual BP checks sit at 75.9% (England 83.4%; Unsworth Group Practice 72.5%), BMI at 73.2% (England 82.1%), and psychosis alcohol recording at 60.5% (England 81.8%). For discussion: introduce a single-appointment SMI check template and proactive outreach, starting at Unsworth Group Practice. Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Option 3

    Structured recall for unreviewed asthma patients

    Asthma review coverage reached 69.6% of the 1,971 register (England 65.7%, Bolton (LAD) 66.6%) after +38.3% three-year growth, leaving a scale indicator of about 600 patients without a recorded review. For discussion: sustain momentum by offering flexible or remote asthma review slots aligned with Core20 outreach. Low cost, quick to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Proactive older adult care planning (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Two-track Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Physical health check recall (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Older cohort blood pressure review (p5)Last BP reading of patients (80+ yrs with hypertension) in the last 12 months is <= 150/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Preschool booster and MMR recall (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cancer referral and safety netting (p7)Cancer: QOF prevalenceCore20PLUS5, 75% stage 1–2 by 2028PCN
    Telephony and triage workflow review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Lipid therapy recall and prescribing review (p12)Patients with QRISK ≥ 20% treated with lipid lowering therapy · CKD patients treated with lipid lowering therapy · Patients with diabetes (40+ yrs no history of CVD) treated with a statin (denominator incl. PCAs)NHS Long Term Plan (diabetes) and National Diabetes AuditPCN
    Option 2 · Combined SMI physical health check recall (p12)Severe mental illness register · Severe mental illness: QOF prevalence · SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN & Practice
    Option 3 · Structured recall for unreviewed asthma patients (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15